Olema Pharmaceuticals, Inc. (OLMA)

Olema Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	48.3	139.48	68.54	23.7	13.81
Short-Term Investments	457.14	294.61	193.27	180.72	273.44
Cash & Short-Term Investments	505.44	434.09	261.81	204.42	287.25
Cash Growth	16.44%	65.80%	28.07%	-28.84%	-15.15%
Other Current Assets	10.02	4.39	4.71	4.48	3.44
Total Current Assets	515.45	438.47	266.51	208.9	290.69
Net Property, Plant & Equipment	17.98	12.51	10.43	6.75	5.26
Total Assets	533.43	450.98	276.95	215.65	295.95
Accounts Payable	9.25	4.46	2.7	0.37	0.02
Accrued Expenses	41.43	36.13	17.94	15.16	8.07
Current Portion of Leases	1.12	1.17	0.99	1.02	0.93
Total Current Liabilities	51.8	41.76	21.62	16.55	9.02
Long-Term Debt	3	-	-	-	-
Long-Term Leases	0.07	0.26	1.43	1.55	2.36
Total Long-Term Liabilities	3.07	0.26	1.43	1.55	2.36
Total Liabilities	54.87	42.02	23.05	18.1	11.38
Common Stock	0.01	0.01	0	0	0
Additional Paid-in Capital	1,075	843.92	559.18	408.33	388.9
Accumulated Other Comprehensive Income	0.62	0.14	0.35	-1.81	-0.15
Retained Earnings	-597.56	-435.11	-305.63	-208.98	-104.19
Shareholders' Equity	478.56	408.96	253.9	197.55	284.57
Total Liabilities & Equity	533.43	450.98	276.95	215.65	295.95
Total Debt	4.19	1.43	2.42	2.57	3.29
Net Cash (Debt)	501.24	432.66	259.39	201.86	283.96
Net Cash Growth	15.85%	66.80%	28.50%	-28.91%	-16.12%
Net Cash Per Share	5.76	7.37	5.73	5.05	7.18
Book Value	478.56	408.96	253.9	197.55	284.57
Book Value Per Share	5.50	6.96	5.61	4.94	7.20
Tangible Book Value	478.56	408.96	253.9	197.55	284.57
Tangible Book Value Per Share	5.50	6.96	5.61	4.94	7.20

Updated Mar 16, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q